Discover and read the best of Twitter Threads about #Yescarta
Most recents (3)
Very excited to share our new study on determinants of resistance to anti-CD19 CAR T-cells (CART19) in large B-cell lymphomas (LBCLs)! Out today in @Cancer_Cell /1
cell.com/cancer-cell/fu…
cell.com/cancer-cell/fu…
A fantastic collaboration from @StanfordMed and @StanfordCancer led by Brian Sworder, David Kurtz, @StefanAlig, and Matthew Frank with David Miklos & @max_diehn to help improve outcomes following CAR T-cell therapy in lymphomas & beyond /2
We serially profiled plasma & tumor samples from 138 r/rLBCL patients across 2 independent cohorts treated w/ SOC axicabtagene ciloleucel (#axicel #yescarta) @StanfordBMT_CT /3 
$ARKG Tweet series
This series of tweets is my opinion only. Cathie Wood has created a group of ETFs that target the disruptive innovation that is both happening and accelerating. These funds have had stellar performance based upon innovation trends and economic theory.
1/
This series of tweets is my opinion only. Cathie Wood has created a group of ETFs that target the disruptive innovation that is both happening and accelerating. These funds have had stellar performance based upon innovation trends and economic theory.
1/
The $ARKG fund description is a good place to start. This has changed recently to a #CRISPR theme but started more with the sequencing cost declines which would drive diagnostics adoption and precision medicine
2/
2/
Nuevo | Los hospitales públicos pagan 307.200 euros por cada tratamiento personalizado contra la #leucemia infantil.
Ese el coste real de #Kymriah, de @Novartis, que @sanidadgob se niega a revelar. Por @maberalv🔽
bit.ly/2Nmtqaf
#CART #Transparencia #Salud
Ese el coste real de #Kymriah, de @Novartis, que @sanidadgob se niega a revelar. Por @maberalv🔽
bit.ly/2Nmtqaf
#CART #Transparencia #Salud
@Novartis @sanidadgob @maberalv Este precio real ha sido negociado en secreto con @Novartis. Los acuerdos de confidencialidad son habituales, y @sanidadgob solo dio a conocer el precio máximo que estaba dispuesto a pagar. Hoy sabemos que es un poco más bajo🔽
bit.ly/2Nmtqaf
#CART #Transparencia
bit.ly/2Nmtqaf
#CART #Transparencia
@Novartis @sanidadgob @maberalv Para revelarlo, hemos tenido que encontrar tres contratos públicos de diferentes centros médicos que reflejan el mismo precio unitario en los tratamientos que adquieren. También publicamos el precio real de #Yescarta, otra terapia #CART contra el cáncer:
bit.ly/2Nmtqaf
bit.ly/2Nmtqaf
